Induction of myogenesis in mesenchymal cells by MyoD depends on their degree of differentiation

Developmental Biology

Volumn 178, Issue 2, 1996, Pages 459-471

  Filvaroff, Ellen H ^a   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYBRID PROTEIN;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION; MESENCHYME; MUSCLE DEVELOPMENT; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; TISSUE INDUCTION;

ANIMALIA;

EID: 0030587614     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1996.0231     Document Type: Article

References (71)

1. Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., and Weintraub, H. (1990). The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
2. Bengal, E., Flores, O., Rangarajan, P. N., Chen, A., Weintraub, H., and Verma, I. M. (1994). Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc. Natl. Acad. Sci. USA 91, 6221-6225.
3. Bengal, E., Ransone, L., Scharfmann, R., Dwarki, V. J., Tapscott, S. J., Weintraub, H., and Verma, I. M. (1992). Functional antagonism between c-jun and MyoD proteins: A direct physical association. Cell 68, 507-519.
4. Blackwell, T. K., and Weintraub, H. (1990). Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250, 1104-1110.
5. Blau, H. M., Chiu, C-P., and Webster, C. (1983). Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32, 1171-1180.
6. Boukamp, P., Chen, J., Gonzales, F., Jones, P. A., and Fusenig, N. E. (1992). Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD 1 transfection, 5-aza-2′deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT. J. Cell Biol. 116, 1257-1271.
7. Braun, T., Bober, E., Buschhausen-Denker, G., Kohtz, S., Grzeschik, K. H., and Arnold, H. H. (1989). Differential expression of myogenic determination genes in muscle cells: Possible autoactivation by the Myf gene products. EMBO J. 8, 3617-3625.
8. Chen, J., and Jones, P. A. (1990). Potentiation of MyoD 1 activity by 5-aza-2′-deoxycytidine. Cell Growth Different. 1, 383-392.
9. Choi, J., Costa, M. L., Mermelstein, C. S., Chagas, C., Holtzer, S., and Holtzer, H. (1990). MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc. Natl. Acad. Sci. USA 87, 7988-7992.
10. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Christy, B. A., Sanders, L. K., Lau, L. F., Copeland, N. G., Jenkins, N. A., and Nathans, D. (1991). An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. USA 88, 1815-1819.
12. Church, G. M., Ephrussi, A., Gilbert, W., and Tonegawa, S. (1985). Cell type specific contacts to immunoglobulin enhancers in nuclei. Nature 313, 798-801.
13. Crescenzi, M., Fleming, T. P., Lassar, A. B., Weintraub, H., and Aaronson, S. A. (1990). MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA 87, 8442-8446.
14. Davis, R. L., Weintraub, H., and Lassar, A. B. (1987). Expression of a single transfected cDN A converts fibroblasts to myoblasts. Cell 51, 987-1000.
15. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J-Y., Huang, C-M., Lee, W-H., Marsilio, E., Paucha, E., and Livingston, D. M. (1988). SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54, 275-283.
16. Dias, P. D., Parham, D. M., Shapiro, D. N., Tapscott, S. J., and Houghton, P. J. (1992). Monoclonal antibodies to the myogenic regulatory protein MyoD1: Epitope mapping and diagnostic utility. Cancer Res. 52, 6431-6439.
17. Edmondson, D. G., Brennan, T. J., and Olson, E. N. (1991). Mitogenic repression of myogenin autoregulation. J. Biol. Chem. 266, 21343-21346.
18. Edmondson, D. G., and Olson, E. N. (1993). Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem. 268, 755-758.
19. Ephrussi, A., Church, G. M., Tonegawa, S., and Gilbert, W. (1985). B-lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227, 134-140.
20. Greaves, M. F. (1986). Differentiation-linked leukomogenesis in lymphocytes. Science 234, 697-700.
21. Grigoriadis, A. E., Heersche, J. N. M., and Aubin, J. E. (1988). Differentiation of muscle, fat, cartilage, and bone in progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J. Cell. Biol. 106, 2139-2151.
22. Grigoriadis, A. E., Heersche, J. N. M., and Aubin, J. E. (1990). Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. Dev. Biol. 142, 313-318.
23. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
24. Hopwood, N. D., Pluck, A., and Gurdon, J. B. (1991). Xenopus myf-5 marks early muscle cells and can activate muscle genes ectopically in early embryos. Development 111, 551-560.
25. Hsu, H. L., Cheng, J. T., Chen, Q., and Baer, R. (1991). Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 11, 3037-3042.
26. α. Proc. Natl. Acad. Sci. USA 92, 9856-9860.
27. Jabs, E. W., Muller, U., Li, X., Ma, L., Luo, W., Haworth, I. S., Klisak, I., Sparkes, R., Warman, M. L., Mulliken, J. B., Snead, M. L., and Maxson, R. (1993). A mutation in the homeodomain of the human msx2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75, 443-450.
28. Jen, Y., Weintraub, H., and Benezra, R. (1992). Overexpression of Id protein inhibits the muscle differentiation program: In vivo association of Id with E2A proteins. Genes Dev. 6, 1466-1479.
29. Johnson, J. E., Birren, S. J., Saito, T., and Anderson, D. J. (1992). DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer. Proc. Natl. Acad. Sci. USA 89, 3596-3600.
30. Kadesch, T. (1992). Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol. Today 13, 31-36.
31. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766.
32. Kawaguchi, N., DeLuca, H. F., and Noda, M. (1992). Id gene expression and its suppression by 1,25-dihydroxyvitamin D3 in rat osteoblast osteosarcoma cells. Proc. Natl. Acad. Sci. USA 89, 4569-4572.
33. Lassar, A. B., Thayer, M. J., Overell, R. W., and Weintraub, H. (1989a). Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58, 659-667.
34. Lassar, A. B., Buskin, J. N., Lockshon, D., Davis, R. L., Apone, S., Hauschka, S. D., and Weintraub, H. (1989b). MyoD is a sequence-specific DNA binding protein requiring a myc homology to bind to the muscle creatine kinase enhancer. Cell 58, 823-831.
35. Lassar, A. B., Davis, R. L., Wright, W. E., Kadesch, T., Murre, C., Voronova, A., Baltimore, D., and Weintraub, H. (1991). Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66, 305-315.
36. Lenardo, M., Pierce, J. W., and Baltimore, D. (1987). Protein-binding sites in Ig enhancers determine transcriptional activity and inducibility. Science 236, 1573-1577.
37. Li, L., Chambard, J-C., Karin, M., and Olson, E. N. (1992a). Fos and jun repress transcriptional activation by myogenin and MyoD: The amino terminus of jun can mediate repression. Genes Dev. 6, 676-689.
38. Li, L., Zhou, J., James, G., Heller-Harrison, R., Czech, M. P., and Olson, E. N. (1992b). FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71, 1181-1194.
39. Miner, J. H., Miller, J. B., Wold, B. J. (1992). Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. Development 114, 853-860.
40. Miner, J. H., and Wold, B. J. (1991). c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol. Cell. Biol. 11, 2842-2851.
41. Murray, S. S., Glackin, C. A., Winters, K. A., Gazit, D., Kahn, A. J., and Murray, E. J. (1992). Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J. Bone Miner. Res. 7, 1131-1138.
42. Murre, C., McCaw, P. S., and Balitmore, D. (1989a). A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777-783.
43. Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N., Hauschka, S. D., Lassar, A. B., Weintraub, H., and Baltimore, D. (1989b). Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537-544.
44. Nair, B. C., Majeska, R. J., and Rodan, G. A. (1987). Rat alkaline phosphatase. Arch. Biochem. Biophys. 254, 18-27.
45. Neuhold, L. A., and Wold, B. (1993). HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id. Cell 74, 1033-1042.
46. Ogata, T., and Noda, M. (1991). Expression of Id, a negative regulator of helix-loop-helix DNA binding proteins, is down-regulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3E1. Biochem. Biophys. Res. Commun. 180, 1194-1199.
47. Olson, E. N. (1990). The MyoD family, a paradigm for development? Genes Dev. 4, 1454-1461.
48. Olson, E. N., and Klein, W. H. (1994). bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes. Dev. 8, 1-8.
49. Rosenthal, N., Kornhauser, J. M., Donoghue, M., Rosen, K. M., and Merlie, J. P. (1989). Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7780-7784.
50. Rupp, R. A. W., Snider, L., and Weintraub, H. (1994). Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev. 8, 1311-1323.
51. Sambrook, J. (1989). "Molecular Cloning: A Laboratory Manual" (J. Sambrook, E. F. Fritsch, and T. Maniatis, Eds.), 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
52. Satokata, I., and Maas, R. (1994). Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nature Genetics 6, 348-355.
53. Schafer, B. W., Blakely, B. T., Darlington, G. J., and Blau, H. M. (1990). Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature 344, 454-458.
54. Song, K., Wang, Y., and Sassoon, D. (1992). Expression of Hox-7.1 in myoblasts inhibits terminal differentiation and induces cell transformation. Nature 360, 477-481.
55. Sorrentino, V., Pepperkok, R., Davis, R. L., Ansorge, W., and Philipson, L. (1990). Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature 345, 813-815.
56. Sun, X-H., and Baltimore, D. (1991). An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64, 459-470.
57. Sun, X-H., Copeland, N. G., Jenkins, N. A., and Baltimore, D. (1991). Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol. Cell. Biol. 11, 5603-5611.
58. Tapscott, S. J., Davis, R. L., Thayer, M. J., Cheng, P-F., Weintraub, H., and Lassar, A. B. (1988). MyoD1: A nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242, 405-411.
59. Tapscott, S. J., Thayer, M. J., and Weintraub, H. (1993). Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259, 1450-1453.
60. Taylor, S. M., and Jones, P. A. (1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17, 771-779.
61. Teboul, L., Gaillard, D., Staccini, L., Inadera, H., Amri, E-Z., and Grimaldi, P. A. (1995). Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem. 270, 28183-28187.
62. Thayer, M. J., Tapscott, S. J., Davis, R. L., Wright, W. E., Lassar, A. B., and Weintraub, H. (1989). Positive autoregulation of the myogenic determination gene MyoD1. Cell 58, 241-248.
63. Thayer, M. J., and Weintraub, H. (1993). A cellular factor stimulates the DNA-binding activity of MyoD and E47. Proc. Natl. Acad. Sci. USA 90, 6483-6487.
64. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S., Zhuang, Y., and Lassar, A. (1991). The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 251, 761-766.
65. Weintraub, H., Tapscott, S. J., Davis, R. L., Thayer, M. J., Adam, M. A., Lassar, A. B., and Miller, A. D. (1989). Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 86, 5434-5438.
66. Woloshin, P., Song, K., Degnin, C., Killary, A. M., Goldhamer, D. J., Sassoon, D., and Thayer, M. J. (1995). Msx1 inhibits MyoD expression in fibroblast × 10T1/2 cell hybrids. Cell 82, 611-620.
67. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989). Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617.
68. Yaffe, D., and Saxel, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-726.
69. Yamaguchi, A., and Kahn, A. J. (1991). Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif. Tissue Int. 49, 221-225.
70. Yamaguchi, A., Katagiri, T., Ikeda, T., Wozney, J. M., Rosen, V., Wang, E. A., Kahn, A. J., Suda, T., and Yoshiki, S. (1991). Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell. Biol. 113, 681-687.
71. Zhuang, Y., Kim, C. G., Bartelmez, S., Cheng, P., Groudine, M., and Weintraub, H. (1992). Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. Proc. Natl. Acad. Sci. USA 89, 12132-12136.